Citations

Showing 10 of 108135 citations.

CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis
Ligresti, Giovanni , Caporarello, Nunzia , Meridew, Jeffrey A., Jones, Dakota L. , Tan, Qi , Choi, Kyoung Moo , Haak, Andrew J. , Aravamudhan, Aja, Roden, Anja C. , Prakash, Y. S. , Lomberk, Gwen , Tschumperlin, Daniel J. , Prakash, Y S , Lomberk, Gwen L , Caporarello, Nunzia , Urrutia, Raúl

Mayo Clinic

JCI Insight | May 16, 2019 | Volume: 4 | Issue: 12 | Pages: No page available

10.1172/jci.insight.127111 | PMID 31095524 Get It

Pulmonary fibrosis is a devastating disease characterized by accumulation of activated fibroblasts and scarring in the lung. While fibroblast activation in physiological wound repair reverses spontaneously, fibroblast activation in fibrosis is aberrantly sustained. Here we identified histone 3 lysine 9 methylation (H3K9me) as a critical epigenetic modification that sustains fibroblast activation by repressing the transcription of genes essential to returning lung fibroblasts to an inactive state. We show that the histone methyltransferase G9a (EHMT2) and chromobox homolog 5 (CBX5, also known as HP1α), which deposit H3K9me marks and assemble an associated repressor complex, respectively, are essential to initiation and maintenance of fibroblast activation specifically through epigenetic repression of peroxisome proliferator–activated receptor γ coactivator 1 α gene ( PPARGC1A, encoding PGC1α). Both TGF-β and increased matrix stiffness potently inhibit PGC1α expression in lung fibroblasts through engagement of the CBX5/G9a pathway. Inhibition of the CBX5/G9a pathway in fibroblasts elevates PGC1α, attenuates TGF-β– and matrix stiffness–promoted H3K9 methylation, and reduces collagen accumulation in the lungs following bleomycin injury. Our results demonstrate that epigenetic silencing mediated by H3K9 methylation is essential for both biochemical and biomechanical fibroblast activation and that targeting this epigenetic pathway may provide therapeutic benefit by returning lung fibroblasts to quiescence.
Report From Advances in Inflammatory Bowel Diseases 2018: An Update
Ashburn, Jean, Fleshner, Phillip , Kotze, Paulo Gustavo , Remzi, Feza H. , Strong, Scott A. , Kotze, Paulo G , Lightner, Amy L.

Mayo Clinic

Diseases of the Colon & Rectum | May 16, 2019 | Volume: 62 | Issue: 6 | Pages: 659-660

10.1097/dcr.0000000000001402 | PMID 31094957 Get It

Visual Acuity and Ophthalmic Outcomes in the Year After Cataract Surgery Among Children Younger Than 13 Years
Repka, Michael X. , Dean, Trevano W., Kraker, Raymond T. , Bothun, Erick D. , Morrison, David G., Lambert, Scott R. , Stahl, Erin D., Wallace, David K. , Herlihy, Erin P.

Mayo Clinic

JAMA Ophthalmology | May 16, 2019 | Volume: 137 | Issue: 7 | Pages: 817

10.1001/jamaophthalmol.2019.1220 | PMID 31095258 Get It

TO THE EDITOR:
Bydon, Mohamad , Alvi, Mohammed Ali , Alvi, Mohammed Ali

Mayo Clinic

Spine | May 16, 2019 | Volume: 44 | Issue: 11 | Pages: E693-E696

10.1097/brs.0000000000003039 | PMID 31095075 Get It

The authors reply
Sakusic, Amra , Rabinstein, Alejandro A.

Mayo Clinic

Critical Care Medicine | May 16, 2019 | Volume: 47 | Issue: 6 | Pages: e532-e532

10.1097/ccm.0000000000003758 | PMID 31095028 Get It

Trends and Outcomes in Sepsis Hospitalizations With and Without Atrial Fibrillation: A Nationwide Inpatient Analysis
Desai, Rupak , Hanna, Bishoy , Singh, Sandeep , Omar, Ahmed H., Deshmukh, Abhishek , Kumar, Gautam , Sachdeva, Rajesh , Sachdeva, Rajesh , Omar, Ahmed, Foreman, Marilyn G. , Desai, Rupak

Mayo Clinic

Critical Care Medicine | May 16, 2019 | Volume: 47 | Issue: 8 | Pages: e630-e638

10.1097/ccm.0000000000003806 | PMID 31094740 Get It

Objectives: Atrial fibrillation is frequently seen in sepsis-related hospitalizations. However, large-scale contemporary data from the United States comparing outcomes among sepsis-related hospitalizations with versus without atrial fibrillation are limited. The aim of our study was to assess the frequency of atrial fibrillation and its impact on outcomes of sepsis-related hospitalizations. Design: Retrospective cohort study. Setting: The National Inpatient Sample databases (2010–2014). Patients: Primary discharge diagnosis of sepsis with and without atrial fibrillation were identified using prior validated International Classification of Diseases, 9th Edition, Clinical Modification codes. Interventions: None. Measurements and Main Results: Overall, 5,808,166 hospitalizations with the primary diagnosis of sepsis, of which 19.4% (1,126,433) were associated with atrial fibrillation. The sepsis-atrial fibrillation cohort consisted of older (median [interquartile range] age of 79 yr [70–86 yr] vs 67 yr [53–79 yr]; p < 0.001) white (80.9% vs 68.8%; p < 0.001) male (51.1% vs 47.5%; p < 0.001) patients with an extended length of stay (median [interquartile range] 6 d [4–11 d] vs 5 d [3–9 d]; p < 0.001) and higher hospitalization charges (median [interquartile range] $44,765 [$23,234–$88,657] vs $35,737 [$18,767–$72,220]; p < 0.001) as compared with the nonatrial fibrillation cohort. The all-cause mortality rate in the sepsis-atrial fibrillation cohort was significantly higher (18.4% and 11.9%; p = 0.001) as compared with those without atrial fibrillation. Although all-cause mortality (20.4% vs 16.6%) and length of stay (median [interquartile range] 7 d [4–11 d] vs 6 d [4–10 d]) decreased between 2010 and 2014, hospitalization charges increased (median [interquartile range] $41,783 [$21,430–$84,465] vs $46,251 [$24,157–$89,995]) in the sepsis-atrial fibrillation cohort. The greatest predictors of mortality in the atrial fibrillation-sepsis cohort were African American race, female gender, advanced age, and the presence of medical comorbidities. Conclusions: The presence of atrial fibrillation among sepsis-related hospitalizations is a marker of poor prognosis and increased mortality. Although we observed rising trends in sepsis and sepsis-atrial fibrillation–related hospitalizations during the study period, the rate and odds of mortality progressively decreased.
Trends in the Use of Laparoscopy and Robotics for Colorectal Cancer in Florida
Spaulding, Aaron , Cochuyt, Jordan J., Naessens, James M. , Merchea, Amit , Spaulding, Aaron C. , Naessens, James , Colibaseanu, Dorin T, Spaulding, Aaron , Osagiede, Osayande , Colibaseanu, Dorin

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | May 16, 2019 | Volume: 29 | Issue: 7 | Pages: 926-933

10.1089/lap.2019.0016 | PMID 31094645 Get It

Abstract Background: Laparoscopy and more recently robotics are increasingly used for colorectal cancer surgery in the United States. We examined the current trends of minimally invasive surgical resections for colorectal cancer in Florida. Methods: The Florida Inpatient Discharge Dataset was used to examine the clinical data of patients who underwent elective surgery for colorectal cancer during 2013–2015. Multivariate analyses were performed to compare patient characteristics associated with the use of open and minimally invasive surgeries. Results: A total of 10,513 patients were analyzed; 5451 (52%) had open surgery, 4403 (42%) laparoscopy, and 659 (6%) robotic surgery. The rates of minimally invasive surgery (MIS) increased from 46.95% in 2013 to 48.72% in 2015. Among minimally invasive surgical procedures, the use of robotics increased from 9.82% in 2013 to 15.48% in 2015. Metastatic cancer (odds ratio [OR] 0.61, confidence interval [CI] 0.55–0.67), Elixhauser score of 3–5 (OR 0.85, CI 0.76–0.95) or more than 5 (OR 0.78, CI 0.63–0.97), Medicaid insurance (OR 0.73, CI 0.6–0.89), Black race (OR 0.88, CI 0.77–0.99), and rural residence (OR 0.83, CI 0.69–0.99) were associated with lower odds of MIS than open surgery. Conclusions: This study demonstrates that the overall rates of MIS for colorectal cancer in Florida increased from 2013 to 2015. Socially deprived and very sick patient populations with colorectal cancer are less likely to undergo MIS.
Treatment of Cartilage Defects With the Matrix‐Induced Autologous Chondrocyte Implantation Cookie Cutter Technique
Hevesi, Mario , Krych, Aaron J. , Saris, Daniël B.F. , Krych, Aaron J , Hevesi, Mario

Mayo Clinic

Arthroscopy Techniques | May 16, 2019 | Volume: 8 | Issue: 6 | Pages: No page available

10.1016/j.eats.2019.01.022 | PMID 31334015 Get It

Abstract Focal cartilage defects lead to significant pain and disability, prompting the development of various options for biologic restoration of the articular surface. Although each technique and biologic implant provides various advantages and associated limitations, matrix‐induced autologous chondrocyte implantation (MACI) has gained popularity given promising long‐term results. We present a technique for the facile implantation of MACI membranes using cookie cutter instrumentation to aid in defect debridement and graft preparation. The technique described allows for efficient operative workflow while ensuring the creation of vertical, stable defect edges and a form‐fitting MACI membrane in a readily implemented fashion. Technique Video video See video under supplementary data.
Expression of ICOSL is associated with decreased survival in invasive breast cancer
Wang, Bin , Jiang, Huayong , Zhou, Tingyang, Ma, Ning , Liu, Wei , Zuo, Li, Liu, Wei , Wang, Yajie

Mayo Clinic

PeerJ | May 16, 2019 | Volume: 7 | Issue: No issue available | Pages: e6903

10.7717/peerj.6903 | PMID 31143539 Get It

BackgroundInducible co-stimulator (ICOS) is a CD28-related molecule exclusively expressed on activated T cells and plays a critical role in modulating the immune response in breast cancer. The blockage of ICOS pathway has been shown to inhibit the activity of Type 2 T helper cells, thus potentially protecting against cancer growth. The current study aims to investigate the correlation between inducible co-stimulator ligand (ICOSL) expression in tumor tissues and the prognoses of patients with invasive breast cancer.MethodsTumor samples from 562 Chinese patients with invasive breast carcinomas were collected between 2003 and 2010. The expression of ICOSL on breast tumor and adjacent non-cancerous tissue was determined via immunohistochemistry. The overall survival (OS) of patients with positive and negative ICOSL expression were described using Kaplan–Meier curves, respectively. Parametric correlation method was used to analyze the correlation between ICOSL expression and other clinicopathological parameters. ICOSL was selected as a dependent variable for multivariate analysis.ResultsPositive ICOSL expression was identified on the plasma membrane in both cytoplasm and the nucleus of breast cancer cells. Membrane-expressed ICOSL is determined as an independent prognostic factor for OS in breast cancer but without significantly correlating with other clinicopathologic parameters such as age, menopausal status, depth of invasion, lymph node metastasis status, histologic classification, etc.ConclusionOur study suggests that the up-regulated expression of ICOSL protein in breast tumor cells can be associated with poor prognoses in invasive breast carcinomas.
The Role of Outfracture in Correcting Post-Rhinoplasty Nasal Obstruction
Pontell, Jonathan, Slavit, David H., Kern, Eugene B.

Mayo Clinic

Ear, Nose & Throat Journal | May 16, 2019 | Volume: 77 | Issue: 2 | Pages: 106-112

10.1177/014556139807700209 Get It

Post-rhinoplasty nasal obstruction is often related to narrowing in the region of the nasal valve. Correction of this obstruction can include inferior turbinectomy, septoplasty spreader grafts and nasal valvuloplasty. The authors have seen cases of severe valve stenosis related to infracture after osteotomy which did not respond to any of the aforementioned procedures. These patients were treated with revision osteotomy with outfracture. We discuss patient selection and surgical technique for revision osteotomy with outfracture as well as a cadaver dissection demonstrating the effects of infracture and outfracture on valve area. The clinical results, based on patient satisfaction and pre- and postoperative photographs, are presented. Revision osteotomy with outfracture should be included in the surgeon's armamentarium for the treatment of post-rhinoplasty nasal obstruction.